ADAM17 and renal cell carcinoma: This hypothesis is strengthened by a study describing a reciprocal negative feedback loop between miR-145 and ADAM17 expression in renal cell carcinoma, in which miR-145 negatively regulates ADAM17 and ADAM17, in turn, negatively regulates miR-145 expression [74].